CPTx
PrivateLast Round
Grant
Aug 14, 2025
Total Funding Raised
$30.16M
Company Overview
CPTx is a biotechnology company pioneering the development of in vivo genetic medicines built with single-stranded DNA (ssDNA).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CPTx Comps
Public and private peers based on sector, stage, and business model.
CPTx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 14, 2025 | ||||
| Series A | Sep 12, 2024 |
Key People
Founding team and executive leadership
CPTx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eureka Network | Grant |
| BlueYard Capital | Series A |
| Bayern Kapital | Series A |
| European Union | Grant |
| SPRIND | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2025
David Maier appointed to lead gxstrands business unit.
- Apr 22, 2025
McDavid Stilwell appointed as Chief Financial Officer.
CPTx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CPTx's valuation, stock price, and market status.
